NDC 65862-984
Atracurium Besylate
Atracurium Besylate
Atracurium Besylate is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Atracurium Besylate.
| Product ID | 65862-984_5176be07-3121-49fb-9eb9-638903753a31 |
| NDC | 65862-984 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Atracurium Besylate |
| Generic Name | Atracurium Besylate |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2015-04-08 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA206010 |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | ATRACURIUM BESYLATE |
| Active Ingredient Strength | 50 mg/5mL |
| Pharm Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |